The 4 different case studies below allow you to select appropriate treatment plans for each of these patients.* For each case, alternate plans are presented showing where STIVARGA® (regorafenib) might best fit for treatment of that patient.
Sandra
- Meet Sandra:
- Age 67
- Stage IV rectal cancer
- KRAS mutant
Kevin
- Meet Kevin:
- Age 64
- Stage IV colon cancer
- KRAS mutant
Hector
- Meet Hector:
- Age 61
- Stage IV colon cancer (T4, N2, M1)
- KRAS wild-type
Jane
- Meet Jane:
- Age 60
- Stage IV recurrent colon cancer
- KRAS wild-type